ClinicalTrials.gov
public full text
Public Domain
Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study)
The purpose of this study is to evaluate two different treatment strategies in patients admitted to hospital with Community Acquired Pneumonia. The investigators hypothesize treatment according to both procalcitonin (PCT) and C-reactive protein (CRP) will be effective in reducing the length of antibiotic treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Managing Bacterial Pneumonia in Children Without Antimicrobials#1124518
- Point-of-Care Multiplex for Adult Patients With Severe Community-acquired Pneumonia#890500
- Rapid Diagnostic Supporting Antimicrobial Stewardship in Patients With Pneumonia#640435
- Shortened Antibiotic Treatment of 5 Days in Community-Acquired Pneumonia#1296092
- Feasibility Study of Contemporary Diagnostics for Patients With Suspected Hospital-Acquired Pneumonia.#18665
Record · ID 1310518
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive